Anavex Life Sciences Corp (AVXL)
3.445
+0.06
(+1.62%)
USD |
NASDAQ |
Apr 26, 15:09
Anavex Life Sciences Cash and Short Term Investments (Quarterly): 143.76M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 143.76M |
| September 30, 2023 | 151.02M |
| June 30, 2023 | 154.82M |
| March 31, 2023 | 153.47M |
| December 31, 2022 | 143.62M |
| September 30, 2022 | 149.16M |
| June 30, 2022 | 153.20M |
| March 31, 2022 | 153.34M |
| December 31, 2021 | 151.15M |
| September 30, 2021 | 152.11M |
| June 30, 2021 | 157.56M |
| March 31, 2021 | 75.86M |
| December 31, 2020 | 47.36M |
| September 30, 2020 | 29.25M |
| June 30, 2020 | 27.62M |
| March 31, 2020 | 26.56M |
| December 31, 2019 | 27.46M |
| September 30, 2019 | 22.19M |
| June 30, 2019 | 21.25M |
| March 31, 2019 | 19.46M |
| December 31, 2018 | 20.72M |
| September 30, 2018 | 22.93M |
| June 30, 2018 | 25.83M |
| March 31, 2018 | 25.66M |
| December 31, 2017 | 28.05M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.44M |
| June 30, 2017 | 24.79M |
| March 31, 2017 | 23.35M |
| December 31, 2016 | 21.16M |
| September 30, 2016 | 9.187M |
| June 30, 2016 | 9.727M |
| March 31, 2016 | 11.95M |
| December 31, 2015 | 13.85M |
| September 30, 2015 | 15.29M |
| June 30, 2015 | 7.961M |
| March 31, 2015 | 6.311M |
| December 31, 2014 | 6.981M |
| September 30, 2014 | 7.262M |
| June 30, 2014 | 8.180M |
| March 31, 2014 | 9.194M |
| December 31, 2013 | 0.0959M |
| September 30, 2013 | 0.3451M |
| June 30, 2013 | 0.0016M |
| March 31, 2013 | 0.0005M |
| December 31, 2012 | 0.0798M |
| September 30, 2012 | 0.0114M |
| June 30, 2012 | 0.0182M |
| March 31, 2012 | 0.1786M |
| December 31, 2011 | 0.0091M |
| September 30, 2011 | 0.1347M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
21.25M
Minimum
Jun 2019
157.56M
Maximum
Jun 2021
102.14M
Average
143.76M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Ventyx Biosciences Inc | 252.22M |
| Checkpoint Therapeutics Inc | 4.928M |
| Vertex Pharmaceuticals Inc | 11.22B |
| Sarepta Therapeutics Inc | 1.676B |
| NovaBay Pharmaceuticals Inc | 3.13M |